Researchers Identify Potential Biomarker to Distinguish Two Aggressive Types of Brain Tumors in Children

It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children--from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, could lead to the...
21-Sep-2022 10:00 AM EDT Add to Favorites

Researchers Advance Efforts to Tailor Drug Delivery to Cells’ ‘Power Plants’

In a study using lab-grown cells, Johns Hopkins Medicine researchers specializing in aging report they have successfully delivered a common blood pressure drug directly to the inner membrane of mitochondria, the “power plants” in the cells of...
20-Sep-2022 10:15 AM EDT Add to Favorites

Johns Hopkins Medicine Surpasses 1.5 Million Telemedicine Visits Since Start of Pandemic

Johns Hopkins Medicine physicians and clinicians have conducted more than 1.5 million telemedicine visits with over 420,000 patients in Maryland, Washington, D.C., Florida and across the country since the start of the COVID-19 pandemic, according to...
19-Sep-2022 11:00 AM EDT Add to Favorites

Hopkins Immunotherapy Researchers Named Fellows of the SITC Academy of Immuno-Oncology

Drew Pardoll, M.D., Ph.D., and Suzanne Topalian, M.D., leading cancer immunotherapy investigators in the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy and Kimmel Cancer Center, have been named by the Society for Immunotherapy of...
19-Sep-2022 10:00 AM EDT Add to Favorites

A Cut Above — Two Devices Are Teamed to Simplify, Quicken and Improve Ear Reconstruction

Thanks to two novel tools developed by a Johns Hopkins Medicine resident and a former resident, the traditionally difficult surgery to create a replacement ear from a patient’s rib cartilage may soon be done faster, more simply and accurately.
15-Sep-2022 10:00 AM EDT Add to Favorites

Blocking an Ion Channel Improves Muscle Function and Survival in Mice with Severe Duchenne Muscular Dystrophy

Researchers at Johns Hopkins Medicine report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy...
13-Sep-2022 12:05 PM EDT Add to Favorites

Exercise Hormone Halts Parkinson’s Disease Symptoms in Mouse Study

Researchers from Johns Hopkins Medicine and the Dana Farber Cancer Institute in Boston have shown that a hormone secreted into the blood during endurance, or aerobic, exercise reduces levels of a protein linked to Parkinson’s disease and halts...
12-Sep-2022 11:00 AM EDT Add to Favorites

Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current...
8-Sep-2022 11:00 AM EDT Add to Favorites